Hospitalier Pitié-Salpêtrière

Paris 75013

1 studies enrolling now · 2 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Grade 2 Glioma, Recurrent Glioma, Residual Glioma

Studies at this site

• Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS — Recruiting now
• Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) — Running, not enrolling